Summit Therapeutics PLC $SMMT Shares Sold by Aberdeen Group plc
MarketBeat
Aberdeen Group plc trimmed its stake in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) by 5.1% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,139,530 shares of the company's stock after selling 61,280 shares during
NASDAQ:SMMT